Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A post hoc analysis was performed on patients with ESBL-EC bloodstream infections from 6 published prospective cohorts. Mortality and length of hospital stay in patients treated with BLBLI (amoxicillin-clavulanic acid or piperacillin-tazobactam) vs. carbapenem were compared in 2 cohorts: empirical therapy (ETC) and definitive therapy (DTC). Multivariate analysis was used to minimize confounding.

Abstract & Commentary: B-lactam/B-lactamase Inhibitors for Treatment of Bacteremia due to ESBL-producing E.coli